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We were delighted to receive 14 responses to our editorial on corruption in health systems1 and thank the authors for their excellent contributions. 
It seems that in discussing why health systems researchers 
are reluctant to discuss corruption, this journal has created a 
window of opportunity to discuss this neglected topic. Taken 
together, the responses represent a condensed introduction to 
the field and key areas of concern. 
All the authors agreed that corruption is a very serious 
problem for health systems and recognised the threat that 
it poses to countries’ progress towards universal healthcare. 
Many also draw attention to a considerable shift in the field 
including developments over the last 12 months which go 
some way to showing that policy-makers share the deep 
concerns that have been raised in this series of commentaries. 
Of these, the G20 Osaka Summit Declaration,2 the UN 
General Assembly Declaration on universal healthcare3 (both 
of which referred to the need to address corruption) and 
the ground work for establishment of a coalition of actors 
under ‘GNACTA’ (the Global Network on Anti-Corruption, 
Transparency and Accountability) led by the World Health 
Organization (WHO), the Global Fund, and the United 
Nations Development Programme4 seem the most important. 
While questions remain about whether there are enough 
conversations about corruption going on in the corridors of 
power, as pointed out by Stiernstedt,5 and while Lewis notes 
the major limitations in data on the scale and nature of the 
problem,6 these are unambiguously impressive gains in the 
field given the previous lack of recognition of the problem. 
Mackey argues that, taken together, these constitute a “policy 
window,” a critical space in the congested field of global public 
health in which action from the highest level seems possible.7 
These changes raise new questions as researchers argue 
about what we can do to guide policy and practice. As Clarke 
writes, policy-makers must understand that corruption can 
become a manageable rather than intractable health system 
problem,8 serving as a warning to researchers not to get 
involved in “long, technical discussions over why something 
that should work in theory but does not work in practice.”9 
Kohler reminds us that research should always be part of 
public policy-driven conversation, and we must keep our 
commitment to useful, applied research in mind as we find 
research questions, define methods, and publish and debate 
findings.9 
Definitions however, will always matter when we discuss 
corruption – as Hussman10 and Gaitonde11 argue, demystifying 
them is very important. Kohler,9 as well as Mostert and 
Kaspers,12 each recommend the use of Transparency 
International’s definition, “the abuse of power for private 
gain.” It is a straightforward definition, gets to the point, and 
is well-known, making it useful for advocacy and catalysing 
broad-based support for actions. It also puts power right at the 
heart of studies of corruption. But, the problem for us is that 
this snappy definition does not give the weight to the systemic 
and the organisational drivers of corruption that a health 
systems approach demands. As Vian notes, we need “to focus 
on corruption as a health systems problem.”13 Huss,14 Fotaki,15 
and Lu and colleagues’16 papers also recognise this and call 
for a focus on systemic or institutional corruption, which 
draws the system to the heart of the debate. This also speaks 
to what Clarke calls a public health approach to corruption,8 
looking upstream to its determinants and incorporating early 
identification of risk and development of strong institutions 
to prevent corruption emerging. In this approach, dialogue 
and actions can serve to pre-empt full-blown corruption, 
which once entrenched is much more difficult to address. 
Given these considerations, it can be helpful in some 
circumstances to expand Transparency International’s 
definition. While Gaitonde cautions against looking for a 
single definition of corruption, an adapted version of his 2017 
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definition for use with health systems seems useful: “The abuse 
or complicity in abuse, of public or private position, power 
or authority to benefit oneself, a group, an organization or 
others close to oneself in a way which diverts institutions from 
their core aims; where the benefits may be financial, material 
or non-material.” Such a definition is tangible and provides 
the space for unconfrontational discussion. However, as 
Kohler reminds, it is important to recognise that corruption 
perception and experience may vary in different contexts.9
Anti-corruption – Broad-Based or Targeted? 
Given all these considerations, how do we go about tackling 
corruption? Several responses asked whether it can ever 
be enough just to raise awareness about corruption or 
if researchers should focus instead on developing anti-
corruption strategies? This is somewhat of a false dichotomy; 
anti-corruption strategies demand a nuanced understanding 
of corruption. But the shift in emphasis is critical, 
underpinning the fact that research should only ever be there 
to contribute towards the end goal of reducing corruption as 
a means to support the development of equitable, high quality 
health systems. So what sort of anti-corruption measures do 
we need? Clarke points out that the current legalistic anti-
corruption measure for health systems, such as prohibition, 
criminalisation, legal reform and capacity building, are not 
up to the job,8 and it seems likely that this is the case in other 
sectors where anti-corruption interventions have also been 
spectacularly ineffective. Going forward, we will need well-
evaluated examples of effective anti-corruption interventions. 
We share Clarke’s8 view that there is a strong case for taking a 
public health approach to corruption, addressing its upstream 
determinants. However, it is important that his advice on 
understanding risk and developing a prevention strategy that 
addresses it is not, as is often the case in practice, focussed at 
the micro level, with an excessive focus on individuals, which 
limits the scope for addressing the complex institutional and 
political structures that encourage corruption. 
For an anti-corruption model to be successful, it has to 
help us to make a difference between forms of corruption 
that are (a) ‘survival corruption’ and constitute forms of 
problem solving (b) forms of corruption that appear “petty” 
but which have a profound impact on the health system (c) 
forms of corruption that are well-known about and part of 
the everyday, informal norms within a health system (d) 
more hidden forms of corruption that are underpinned by 
imbalances in political power. Why do we need to know these 
differences? Because each will require a specific approach and 
an array of interventions around which a political consensus 
can be built. Moreover, recognising that we are never likely 
to have enough resources to tackle all forms of corruption, 
especially in resource constrained settings, what we need is 
research that helps to identify the forms of corruption that 
are particularly pernicious and deleterious to the functioning 
of the health system and look for ways to address them. If 
our interest is in making sure that the health system functions 
effectively and maximise use and the quality of care in the 
system then anti-corruption needs a targeted approach. 
Power and Targeted Approaches
A new approach to anti-corruption will also have to take 
power and politics seriously; this element of a health systems 
approach to anti-corruption is often missing from the debates 
that often seek to present the power status-quo, and needs to 
be developed urgently. While strengthening governance and 
improving accountability and transparency, as advocated 
by Vian13 and Lewis,6 are fundamental requirements for 
effectively functioning health systems, anti-corruption 
measures often depend much too much on technocratic 
solutions which do not take politics and the influence of 
informal organisation, networks and norms into account. 
These can work in particular cases, as Lewis describes using 
examples from Eastern Europe6 but overall the evidence 
of effectiveness is limited.17 But strengthening regulatory 
institutions or anti-corruption bureaus is, intrinsically, a good 
idea but there are problems where these institutions have 
been captured by powerful interests. For example, in some 
countries, and even those considered to have well-functioning 
governance structures, disciplinary processes can be used to 
silence whistle blowers.18 
We were surprised, therefore, that the responses included 
little discussion of the power and politics underlying these 
solutions. Reynolds was the only respondent who addressed 
this head-on, providing us with a way of thinking about how 
power operates; from violence, to coercion, sometimes limiting 
what can or cannot be spoken of in different fora.19 This is a 
good starting point, but we need a much better understanding 
of the ways in which power operates in different settings, 
with a detailed understanding of the historical background 
and political economy if we are to come up with contextually 
appropriate, effective anti-corruption measures. 
Just thinking about power makes us question accountability 
models and approaches, some of these rely excessively on 
technology. It is often proposed that informing, empowering 
and supporting those at the bottom (such as community 
groups) will help to reduce corruption. But these groups 
often have the least institutionalised power and are least well-
organised to take on corrupt officials. If technical interventions 
(new computing systems, e-governance, electronic payment 
systems) make it easier to see corruption, are there those with 
the resources, political will and power who will be able to act 
on this information once it is ‘captured.’ If they cannot, then 
we will be in the frustrating position where we know about 
corruption but feel unable to act on it. 
We are proposing a new targeted approach to anti-
corruption that takes informality seriously when considering 
new strategies. Drawing on political economy, our approach 
begins from an understanding that forms of corruption, from 
survival corruption to large scale political graft, emerge from 
the intertwining of policy, health systems (lack of) resources, 
and informal systems (networks, organisations and norms). 
It is in understanding how these intertwine that we can find 
innovative, targeted anti-corruption solutions. What is there 
in the informal systems, based on networks, alliances, and 
organisations, that might support anti-corruption action? Vian 
and others point to a potential role for civil society, although 
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its ability to play this role varies considerably in different 
settings.13 Witvliet argues that a global anti-corruption 
movement is needed to set in motion collective actions that 
can be translated to the national level.20 What health systems 
investments would need to be made and how might policy 
have to be changed? Ideas of developmental governance21 and 
political settlements22 can help to understand these informal 
systems and how best to target interventions. 
Yet as we ask about the actors involved, (who is involved 
in corruption and how, who is likely to support anti-
corruption intervention, why and how?), we have noticed 
an extraordinary gap in the literature. There is very little in 
corruption and anti-corruption work in health that looks at 
the ways in which gender shapes corruption.23 Let us finish 
this response by calling upon researchers to look for targeted 
anti-corruption measures that take both the formal system 
and informal structures into account and think through the 
gendered nature of corruption in terms of how it is manifest 
and who it effects. 
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